Anavex Life Sciences Ownership | Who Owns Anavex Life Sciences?


OverviewForecastFinancialsChartTranscripts

Anavex Life Sciences Ownership Summary


Anavex Life Sciences is owned by 10.22% institutional investors, 3.12% insiders, and 86.66% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 8.45% of AVXL shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.98% of its assets in Anavex Life Sciences shares.

AVXL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAnavex Life Sciences10.22%3.12%86.66%
SectorHealthcare Stocks 231.98%10.74%-142.72%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de7.53M8.45%$26.79M
Blackrock6.39M7.75%$26.97M
Vanguard group5.03M5.90%$17.90M
State street3.29M3.85%$29.26M
Geode capital management2.02M2.27%$7.20M
Susquehanna group, llp1.13M1.36%$12.19M
Two sigma investments, lp1.04M1.21%$9.23M
Nwam870.80K1.02%$4.37M
Summit financial903.39K1.01%$3.22M
Goldman sachs group872.97K0.98%$3.11M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Pvg asset management216.29K1.64%$770.01K
Sheets smith investment management135.95K0.78%$1.21M
Allsquare wealth management52.38K0.27%$482.97K
Nwam870.80K0.24%$4.37M
October effect46.28K0.18%$164.76K
Watts gwilliam26.00K0.07%$349.96K
Saxon interests17.85K0.07%$153.14K
Gsa capital partners llp155.88K0.05%$555.00K
180 wealth advisors117.38K0.05%$417.87K
Summit financial903.39K0.05%$3.22M

Top Buyers

HolderShares% AssetsChange
Susquehanna group, llp1.13M0.00%896.32K
Northwestern mutual wealth management744.47K0.04%740.34K
Goldman sachs group872.97K0.00%569.58K
Jane street group768.96K0.00%550.74K
Summit financial903.39K0.05%459.12K

Top Sellers

HolderShares% AssetsChange
Wealthgarden f.s.---910.48K
Invesco56.70K0.00%-807.26K
Jupiter asset management---804.64K
Pier capital---415.91K
Essential planning, llc.---413.09K

New Positions

HolderShares% AssetsChangeValue
Sheets smith investment management135.95K0.78%135.95K$1.21M
Sheets smith wealth management117.70K0.05%117.70K$419.00K
Xtx topco81.70K0.04%81.70K$727.15K
Watts gwilliam26.00K0.07%26.00K$349.96K
Twinbeech capital lp25.94K0.01%25.94K$230.90K

Sold Out

HolderChange
Twin peaks wealth advisors-1.00
Nelson, van denburg & campbell wealth management group-14.00
Stephens consulting-40.00
Eversource wealth advisors-55.00
Parkside financial bank & trust-60.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202563-68.34%8,715,170-73.43%100.69%29-67.42%21-56.25%
Sep 30, 202582-56.61%9,007,990-72.28%100.73%29-68.48%23-34.29%
Jun 30, 2025184-6.60%32,327,9853.05%372.78%89-11.00%35-23.91%
Mar 31, 20253-98.38%406,643-98.62%-0.04%2-98.04%--100.00%
Dec 31, 202418017.65%29,442,0845.60%343.11%9838.03%3822.58%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF2.53M2.98%-
Vanguard Total Stock Mkt Idx Inv2.73M2.95%169.15K
State Street® SPDR® S&P® Biotech ETF2.68M2.89%-14.42K
iShares Russell 2000 ETF2.03M2.19%567.57K
SPDR® S&P Biotech ETF1.12M1.31%2.50K
Vanguard Institutional Extnd Mkt Idx Tr937.27K1.01%4.80K
Fidelity Small Cap Index848.64K0.92%8.75K
Invesco Biotechnology & Genome ETF764.01K0.89%-2.40K
iShares Russell 2000 Growth ETF702.88K0.76%97.44K
iShares Biotechnology ETF638.44K0.69%46.48K

Recent Insider Transactions


DateNameRoleActivityValue
Jun 14, 2024Donhauser Peter D.O.-Buy$10.32K
May 15, 2024Thomas Steffen-Buy$22.60K
Mar 28, 2024MISSLING CHRISTOPHER U President and CEOSell$374.97K
Jun 28, 2023MISSLING CHRISTOPHER U President and CEOSell$2.14M
May 25, 2022Skarpelos Athanasios Sell$453.00K

Insider Transactions Trends


DateBuySell
2025 Q4--
2025 Q3--
2025 Q2--
2025 Q1--
2024 Q4--

AVXL Ownership FAQ


Who Owns Anavex Life Sciences?

Anavex Life Sciences shareholders are primarily institutional investors at 10.22%, followed by 3.12% insiders and 86.66% retail investors. The average institutional ownership in Anavex Life Sciences's industry, Biotech Stocks , is 381.47%, which Anavex Life Sciences falls below.

Who owns the most shares of Anavex Life Sciences?

Anavex Life Sciences’s largest shareholders are Blackrock funding, inc. /de (7.53M shares, 8.45%), Blackrock (6.39M shares, 7.75%), and Vanguard group (5.03M shares, 5.90%). Together, they hold 22.10% of Anavex Life Sciences’s total shares outstanding.

Does Blackrock own Anavex Life Sciences?

Yes, BlackRock owns 7.75% of Anavex Life Sciences, totaling 6.39M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 26.97M$. In the last quarter, BlackRock decreased its holdings by -254K shares, a -3.82% change.

Who is Anavex Life Sciences’s biggest shareholder by percentage of total assets invested?

Pvg asset management is Anavex Life Sciences’s biggest shareholder by percentage of total assets invested, with 1.64% of its assets in 216.3K Anavex Life Sciences shares, valued at 770.01K$.

Who is the top mutual fund holder of Anavex Life Sciences shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Anavex Life Sciences shares, with 2.98% of its total shares outstanding invested in 2.53M Anavex Life Sciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools